1. Aflibercept-related endophthalmitis and vitreous detachment

   News item 03 June 2023 Pages: 1 - 1

2. Amlodipine: risk of hyperkalaemia

   Review 03 June 2023 Pages: 2 - 2

3. Bupropion may unmask Brugada syndrome and lead to sudden death

   News item 03 June 2023 Pages: 3 - 3

4. Colistimethate-related pseudo-Bartter syndrome

   News item 03 June 2023 Pages: 4 - 4

5. Paracetamol-related hypersensitivity syndrome.

   News item 03 June 2023 Pages: 5 - 5

6. TGA warns of counterfeit semaglutide in Australia

   Media release 03 June 2023 Pages: 6 - 6

7. Unauthorised amoxicillin capsules seized from supermarket in Ottawa, Canada

   Media release 03 June 2023 Pages: 7 - 7

8. Anti-PD-(L)1-sotorasib sequence: high risk of hepatotoxicity

   Clinical study 03 June 2023 Pages: 8 - 8

9. Antipsychotics: examining the risk of OCD

   Clinical study 03 June 2023 Pages: 9 - 9

10. BNT162b2 COVID-19 vaccine safe in children, signal for myocarditis/pericarditis in adolescents

    Clinical study 03 June 2023 Pages: 10 - 10

11. Lower risk of suicidality with most newer anti-seizure medications

    Clinical study 03 June 2023 Pages: 11 - 11

12. TB treatment in elderly: risk factors for ADRs/death examined

    Clinical study 03 June 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 03 June 2023 Pages: 13 - 13

14. Lactobacillus

    Case report 03 June 2023 Pages: 14 - 14

15. Lactobacillus

    Case report 03 June 2023 Pages: 15 - 15

16. Mitragyna speciosa

    Case report 03 June 2023 Pages: 16 - 16

17. Abacavir/dolutegravir/lamivudin

    Case report 03 June 2023 Pages: 17 - 17

18. Abemaciclib

    Case report 03 June 2023 Pages: 18 - 18

19. Abemaciclib/​fulvestrant

    Case report 03 June 2023 Pages: 19 - 19

20. Acarbose/guar-gum

    Case report 03 June 2023 Pages: 20 - 20

21. Acenocoumarol/posaconazole

    Case report 03 June 2023 Pages: 21 - 21

22. Acetylcysteine/ascorbic-acid/methylprednisolone

    Case report 03 June 2023 Pages: 22 - 22

23. Aciclovir

    Case report 03 June 2023 Pages: 23 - 23

24. Aciclovir/lactulose/rifaximin

    Case report 03 June 2023 Pages: 24 - 24

25. Ad26.cov2-s

    Case report 03 June 2023 Pages: 25 - 25

26. Ad5-ncov-tianjin-cansino-biotechnology/methylprednisolone

    Case report 03 June 2023 Pages: 26 - 26

27. Adalimumab

    Case report 03 June 2023 Pages: 27 - 27

28. Adalimumab

    Case report 03 June 2023 Pages: 28 - 28

29. Adalimumab/azathioprine

    Case report 03 June 2023 Pages: 29 - 29

30. Adalimumab/azathioprine/infliximab

    Case report 03 June 2023 Pages: 30 - 30

31. Adalimumab/azathioprine/sulfasalazine

    Case report 03 June 2023 Pages: 31 - 31

32. Adalimumab/infliximab

    Case report 03 June 2023 Pages: 32 - 32

33. Adalimumab/infliximab

    Case report 03 June 2023 Pages: 33 - 33

34. Adalimumab/infliximab

    Case report 03 June 2023 Pages: 34 - 34

35. Adalimumab/itraconazole/rifampicin

    Case report 03 June 2023 Pages: 35 - 35

36. Adalimumab/methotrexate

    Case report 03 June 2023 Pages: 36 - 36

37. Adalimumab/prednisone

    Case report 03 June 2023 Pages: 37 - 37

38. Adalimumab/smallpox-vaccine

    Case report 03 June 2023 Pages: 38 - 38

39. Adenosine

    Case report 03 June 2023 Pages: 39 - 39

40. Adenosine/esmolol

    Case report 03 June 2023 Pages: 40 - 40

41. Albumin-human/midodrine/octreotide

    Case report 03 June 2023 Pages: 41 - 41

42. Alectinib

    Case report 03 June 2023 Pages: 42 - 42

43. Alectinib/brentuximab-vedotin

    Case report 03 June 2023 Pages: 43 - 43

44. Alemtuzumab

    Case report 03 June 2023 Pages: 44 - 44

45. Alemtuzumab/immune-globulin/rituximab

    Case report 03 June 2023 Pages: 45 - 45

46. Allopurinol/methylprednisolone/prednisone

    Case report 03 June 2023 Pages: 46 - 46

47. Alprazolam

    Case report 03 June 2023 Pages: 47 - 47

48. Alteplase/low molecular weight heparins

    Case report 03 June 2023 Pages: 48 - 48

49. Amfetamine

    Case report 03 June 2023 Pages: 49 - 49

50. Amikacin

    Case report 03 June 2023 Pages: 50 - 50